Interferon beta-1a

From WikiMD.org
Jump to navigation Jump to search

Interferon beta-1a

Interferon beta-1a (pronounced as in-ter-FEER-on BAY-tuh-1a) is a type of protein and biopharmaceutical that is used to treat multiple sclerosis (MS). It is produced by mammalian cells that have been genetically engineered to produce it.

Etymology

The term "Interferon" is derived from the word "interfere" as it was discovered due to its ability to "interfere" with viral replication. The "beta-1a" refers to the specific subtype of interferon.

Usage

Interferon beta-1a is used to treat relapsing forms of Multiple Sclerosis, a chronic disease that affects the central nervous system. It is not a cure for MS but it can help to slow the progression of the disease and manage symptoms.

Mechanism of Action

Interferon beta-1a works by reducing inflammation and preventing the damage that inflammation can cause to the protective covering of nerve fibers in the brain and spinal cord.

Related Terms

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski